Literature DB >> 19282354

Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis.

Raymond Gambino1, Janet Piscitelli, Tomy A Ackattupathil, Judy L Theriault, Reynaldo D Andrin, Michael L Sanfilippo, Monina Etienne.   

Abstract

BACKGROUND: Sodium fluoride is the preferred agent to inhibit glycolysis. Its action is not immediate, however, and complete inhibition is delayed for up to 4 hours. A more effective method is needed. Acidification of blood combined with the addition of NaF and EDTA appears to be such a method. We studied whether acidification was indeed more effective than NaF.
METHODS: We conducted 6 independent studies over a 10-month period at 3 Quest Diagnostics laboratory sites. In each study, we drew venous blood from 6-24 nonfasting employee volunteers into 3 or 4 different serum- or plasma-collection tubes, which were stored under different conditions and aliquoted at different times. We analyzed the aliquots in duplicate by means of a hexokinase-based enzymatic method.
RESULTS: The mean glucose concentration decreased by 0.3% at 2 h and by 1.2% at 24 h when blood was drawn into tubes containing citrate buffer, NaF, and EDTA. In contrast, the mean glucose concentration decreased by 4.6% at 2 h and by 7.0% at 24 h when blood was drawn into tubes containing NaF and sodium oxalate.
CONCLUSIONS: Acidification should replace NaF alone as the recommended method for obtaining an accurate glucose concentration. Diagnostic cut points based on blood samples collected into tubes containing NaF as the only inhibitor of glycolysis are likely to be too low.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282354     DOI: 10.1373/clinchem.2008.121707

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Inhibition of Glycolysis for Glucose Estimation in Plasma: Recent Guidelines and their Implications.

Authors:  Shalini Gupta; Harpreet Kaur
Journal:  Indian J Clin Biochem       Date:  2013-11-22

2.  Are tubes containing sodium fluoride still needed for the measurement of blood glucose in hospital laboratory practice?

Authors:  Amira Al-Kharusi; Nuha Al-Lawati; Manal Al-Kindi; Waad-Allah Mula-Abed
Journal:  Oman Med J       Date:  2014-11

3.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

4.  Diagnosis of Gestational Diabetes Mellitus Will Be Flawed until We Can Measure Glucose.

Authors:  David E Bruns; Boyd E Metzger; David B Sacks
Journal:  Clin Chem       Date:  2020-02-01       Impact factor: 8.327

5.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

6.  Stabilization of glucose in blood samples: why it matters.

Authors:  David E Bruns; William C Knowler
Journal:  Clin Chem       Date:  2009-03-12       Impact factor: 8.327

Review 7.  A1C versus glucose testing: a comparison.

Authors:  David B Sacks
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 8.  Principles of fluoride toxicity and the cellular response: a review.

Authors:  Nichole R Johnston; Scott A Strobel
Journal:  Arch Toxicol       Date:  2020-03-09       Impact factor: 5.153

9.  Impact of blood sample collection and processing methods on glucose levels in community outreach studies.

Authors:  Michael Turchiano; Cuong Nguyen; Arthur Fierman; Mark Lifshitz; Antonio Convit
Journal:  J Environ Public Health       Date:  2013-01-10

10.  It's time for a better blood collection tube to improve the reliability of glucose results.

Authors:  Michael J Peake; David E Bruns; David B Sacks; Andrea R Horvath
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.